FineMark National Bank & Trust’s Emergent Biosolutions EBS Stock Holding History

FineMark National Bank & Trust’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-70	Closed	-$2K	–	1386
2015 Q3	$2K	Buy	+70	New	+$2.31K	﹤0.01%	1241

Other funds holding EBS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

FineMark National Bank & Trust's EBS Position: Q4 2015 in Review

FineMark National Bank & Trust sold out of Emergent Biosolutions (EBS) in Q4 2015, closing a stake of 70 shares — an estimated $2K sold.

FineMark National Bank & Trust first reported a position in EBS in Q3 2015 and held it in 1 quarter. The position peaked at $2K in Q3 2015. 205 funds tracked by Wall St. Rank hold EBS as of Q4 2015.

FineMark National Bank & Trust reported no remaining Emergent Biosolutions position as of Q4 2015 after selling out during the quarter.
FineMark National Bank & Trust sold 70 Emergent Biosolutions shares in Q4 2015, an estimated $2K.
FineMark National Bank & Trust first reported a position in Emergent Biosolutions in Q3 2015 and held it in 1 quarter.
FineMark National Bank & Trust's Emergent Biosolutions position peaked at $2K in Q3 2015.
205 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2015.

Based on FineMark National Bank & Trust's 13F filing for Q4 2015, filed 9 Feb 2016.